BFEC
IDXX icon

Benjamin F. Edwards & Company’s Idexx Laboratories IDXX Stock Holding History

Benjamin F. Edwards & Company’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$807K Buy
1,657
+45
+3% +$22.6K 0.01% 582
2024
Q1 		$870K Sell
1,612
-9
-0.6% -$4.92K 0.02% 540
2023
Q4 		$900K Buy
1,621
+596
+58% +$280K 0.02% 525
2023
Q3 		$448K Hold
1,025
– – 0.02% 547
2023
Q2 		$515K Hold
1,025
– – 0.02% 501
2023
Q1 		$513K Sell
1,025
-12
-1% -$5.74K 0.02% 476
2022
Q4 		$423K Hold
1,037
– – 0.02% 509
2022
Q3 		$338K Hold
1,037
– – 0.02% 523
2022
Q2 		$364K Sell
1,037
-37
-3% -$15.1K 0.02% 506
2022
Q1 		$588K Sell
1,074
-73
-6% -$38.4K 0.03% 433
2021
Q4 		$755K Hold
1,147
– – 0.03% 395
2021
Q3 		$713K Buy
1,147
+73
+7% +$49.1K 0.04% 397
2021
Q2 		$678K Buy
1,074
+9
+0.8% +$4.97K 0.03% 391
2021
Q1 		$521K Sell
1,065
-173
-14% -$86.7K 0.03% 450
2020
Q4 		$619K Buy
1,238
+213
+21% +$95.3K 0.04% 391
2020
Q3 		$403K Hold
1,025
– – 0.03% 439
2020
Q2 		$338K Sell
1,025
-7
-0.7% -$2.03K 0.02% 456
2020
Q1 		$250K Sell
1,032
-181
-15% -$47.2K 0.02% 471
2019
Q4 		$317K Buy
1,213
+6
+0.5% +$1.58K 0.02% 494
2019
Q3 		$328K Sell
1,207
-2
-0.2% -$557 0.03% 452
2019
Q2 		$333K Buy
1,209
+109
+10% +$26.9K 0.03% 431
2019
Q1 		$246K Sell
1,100
-92
-8% -$19K 0.02% 469
2018
Q4 		$222K Buy
1,192
+54
+5% +$11.1K 0.02% 470
2018
Q3 		$284K Hold
1,138
– – 0.03% 449
2018
Q2 		$248K Hold
1,138
– – 0.02% 472
2018
Q1 		$218K Buy
1,138
+38
+3% +$7.01K 0.02% 484
2017
Q4 		$172K Buy
1,100
+1,000
+1,000% +$157K 0.02% 521
2017
Q3 		$16K Buy
+100
New +$15.8K ﹤0.01% 1038

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Benjamin F. Edwards & Company's IDXX Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Idexx Laboratories (IDXX) stake by 2.8% in Q2 2024, buying an estimated $22.6K and bringing the position to 1,657 shares worth $807K. The position accounts for 0.01% of the portfolio, ranked #582.

Benjamin F. Edwards & Company first reported a position in IDXX in Q3 2017 and has held it in 28 quarters since. The position peaked at $900K in Q4 2023. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Benjamin F. Edwards & Company held 1,657 shares of Idexx Laboratories worth $807K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 45 Idexx Laboratories shares in Q2 2024, an estimated $22.6K.
  • Idexx Laboratories made up 0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #582 holding.
  • Benjamin F. Edwards & Company first reported a position in Idexx Laboratories in Q3 2017 and has held it in 28 quarters since.
  • Benjamin F. Edwards & Company's Idexx Laboratories position peaked at $900K in Q4 2023.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.